Vulvar invasive squamous cell carcinoma occurring in a young woman with systemic lupus erythematosus

Background: Although several studies have demonstrated a possible relationship between systemic lupus erythematosus (SLE) and non-Hodgkin's lymphoma, Hodgkin's lymphoma, leukemia and several solid tumors, it is still debatable whether SLE patients have an increased incidence of cancer overall.

Case: We describe a 25-year-old patient with SLE who developed invasive squamous cell carcinoma of the vulva. The patient underwent radical vulvectomy and bilateral groin sentinel lymph node dissection and until to date, one year after surgery, she is alive without evidence of recurrent disease.

Conclusions: Only three cases of vaginal/vulvar cancer associated with SLE have previously been mentioned in the literature, but not described in detail. This is the first detailed case report in the literature of vulvar invasive squamous cell carcinoma occurring in a SLE patient. It can only be speculated that the SLE itself and/or the treatment with immunosuppressive drugs provoked malignant transformation and the development of vulvar squamous cell carcinoma in such a young patient.

Vulvar carcinoma; Radical vulvectomy; Groin lymph nodes; Systemic lupus erythematosus; Corticosteroids; Immunosuppression

[1] Cammarata R.J., Rodnan G.P., Jensen W.N.: "Systemic rheumatic disease and malignant lymphoma". Arch. Intern. Med., 1963, 111, 330.

[2] Lewis R.B., Castor C.W., Knisley R.E., Bole G.G.: "Frequency of neoplasia in systemic lupus erythematosus and rheumatoid arthritis". Arthritis Rheum., 1976, 19, 1256.

[3] Patterssen T., Pukkala E., Teppo L., Friman C.: "Increased risk of cancer in patients with systemic lupus erythematosus". Ann. Rheum. Dis., 1992, 51, 437.

[4] Abu-Shakra M., Gladman D.D., Urowitz M.B.: "Malignancy in systemic lupus erythematosus". Arthritus Rheum., 1996, 39, 1050.

[5] Mellemkjaer L., Anderson V., Linet M.S., Gridley G., Hoover R., Olsen J.H.: "Non-Hodgkin's lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus". Arthritis Rheum., 1997, 40, 761.

[6] Ramsey-Goldman R., Mattai S.A., Schilling E., Chiu Y.L., Alo C.I., Howe H.L., Manzi S.: "Increased risk of malignancy in patients with systemic lupus erythematosus". J. Invest. Med., 1998, 46, 217.

[7] Sultan S.M., Ioannou Y., Isenberg D.A.: "Is there an association of malignancy with SLE? An analysis of 276 patients under longterm review". Rheumatology, 2000, 39, 1147.

[8] Cibere J., Sibley J., Haga M.: "Systemic lupus erythematosus and the risk of malignancy". Lupus, 2001, 10, 394.

[9] Bjomadal L., Lofstrom B., Yin L., Lundberg I.E., Ekbom A.: "Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus". Scand. J. Rheumatol., 2002, 31, 66.

[10] Piura B., Rabinovich A., Cohen Y., Friger M., Glezerman M.: "Squamous cell carcinoma of the vulva in the south of Israel: a study of 50 cases". J. Surg. Oncol., 1998, 67, 174.

[11] Sweeney D.M., Manzi S., Janosky J., Selvaggi K.J., Ferri W., Medsger T.A. Jr., Ramsey-Goldman R.: "Risk of malignancy in women with systemic lupus erythematosus". J. Rheumatol., 1995, 22, 1478.

[12] Nived O., Bengtsson A., Jonsen A., Sturfelt G., Olsson H.: "Malignancies during follow-up in epidemiologically defined SLE inception cohort in southern Sweden". Lupus, 2001, 10, 500.

[13] Dhar J.P., Kmak D., Bhan R., Pishorodi L., Ager J., Sokol R.J.: "Abnormal cervicovaginal cytology in women with lupus: a retrospective cohort study". Gynecol. Oncol., 2001, 82, 4.

[14] Blumenfeld Z., Lorber M., Yoffe N., Scharf Y.: "Systemic lupus erythematosus: predisposition for uterine cervical dysplasia". Lupus, 1994, 3, 59.

[15] Silman A.J., Petrie J., Hazleman B., Evans S.J.W.: "Lymphoproliferative cancer and other malignancy in patients with rheumatoid arthritis treated with azathioprine: a 20 year follow-up study". Ann. Rheum. Dis., 1988, 47, 988.

[16] Matteson E.L., Hickey A.R., Maguire L., Tilson H.H., Urowitz M.B., and members of the Rheumatoid Arthritis Azathioprine Registry Steering Committee: "Occurrence of neoplasia in patients with rheumatoid arthritis enrolled in a DMARD Registry". J. Rheumatol., 1991, 18, 809.

[17] Vasuez S., Kavanaugh A.F., Schneider N.R., Wacholtz M.C., Lipsky P.E.: "Acute nonlymphocytic leukemia after treatment of systemic lupus erythematosus with immunosuppressive agents". J. Rheumatol., 1992, 19, 1625.

[18] Gibbons R.B., Westerman E.: "Acute monlymphocytic leukemia following short-term intermittent, intravenous cyclophosphamide treatment of lupus nephritis". Arthritis Rheum., 1988, 31, 1552.